Your Health, We Care
Capmatinib is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDA-approved test.
from FDA,2023.03
The price of generic capmatinib in LaosCapmatinib has been approved for the trea···【more】
Release date：2024-11-25Recommended：112
There are several generic versions of the Laos Lucius version of capmatinibMET d···【more】
Release date：2024-11-25Recommended：118
Capmatinib acts as a targeted therapy to stop the growth and spread of cancer ce···【more】
Release date：2024-08-07Recommended：117
Capmatinib is a targeted drug manufactured by Novartis for the treatment of adul···【more】
Release date：2024-08-07Recommended：120
Capmatinib prevents the growth and spread of cancer cells by inhibiting MET tyro···【more】
Release date：2024-08-06Recommended：142
